Actuate Therapeutics, Inc. (ACTU)

NGM – Real Time Price. Currency in USD

1.00

-0.01 (-1.29%)

Market open: Aug 12, 2026, 11:13 AM EDT

1.06

+0.05 (4.95%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

Gross Profit

Operating expenses (excl. COGS)

-22M

-25M

-20M

Operating Income

-22M

-25M

-20M

Non-operating income, total

267K

-2M

229K

47K

Pretax income

-22M

-27M

-25M

-20M

Equity in earnings

Taxes

-800

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-22M

-27M

-25M

-20M

Discontinued operations

Net income

-22M

-27M

-25M

-20M

Dilution adjustment

Preferred dividends

Actuate Therapeutics, Inc. (ACTU)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Actuate Therapeutics, Inc. (ACTU)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Actuate Therapeutics, Inc. (ACTU)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Actuate Therapeutics, Inc. (ACTU)

Income Statement (Annual)

Income Statement (Annual)